Advancements across Life Science Sector

  • ID: 4244581
  • Report
  • 15 pages
  • Frost & Sullivan
1 of 3
This Genetic Technology TOE depicts the current landscape across life sciences sector. 3D tissue microenvironment tests, protein-based drugs manufacturing, skin testing, cosmetics developments, and crowdsourcing for clinical trials are profiled. The corresponding industry interactions are also depicted.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Note: Product cover images may vary from those shown
2 of 3
Technological Innovation Profiles:
  • Novel Technologies Being Adopted for Improved Cosmetic Product Development
  • 3D Tissue Microenvironments Result in Improved Drug Testing
  • Streamlining Manufacturing of Protein-based Drugs
  • Digitization of the Clinical Trial Process using Crowdsourcing
  • Top 20 Patent Holders in the Area of Skin Testing
  • Industry Contacts
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown